All Stories

  1. AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
  2. Alcohol delamination and topical mitomycin-C 0.02% for the treatment of corneal intraepithelial neoplasia
  3. Enhancing Visual Quality: The Impact of Alcohol-Assisted Delamination on Corneal Aberrations in Patients with Central Epithelial Basement Membrane Dystrophy
  4. Safety of intravitreal injections with the mobile laminar airflow device Operio after more than 10.000 injections
  5. Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
  6. Combined Multilayered Amniotic Membrane Graft and Fibrin Glue as a Surgical Management of Limbal Dermoid Cyst
  7. Mobile unidirectional airflow device reduces air contamination in an intravitreal outpatient clean room setting
  8. Optic disc pit maculopathy: Covering or filling technique with human amniotic membrane patch to treat the optic disc pit maculopathy?
  9. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  10. TENAYA and LUCERNE
  11. Predictive Role of Fluorescein Angiography in Retinopathy of Prematurity
  12. Faricimab Treat-and-Extend for Diabetic Macular Edema
  13. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
  14. Combined superficial keratectomy, alcohol delamination and amniotic membrane patch with fibrin glue in Salzmann nodular degeneration
  15. Increasing incidence of contact-lens-related Acanthamoeba keratitis in a tertiary ophthalmology department in an Italian population
  16. Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery
  17. Choroidal vascularity analysis in patients with juvenile idiopathic arthritis without acute uveitis
  18. Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection
  19. Efficacy and Safety of PreserFlo MicroShunt Implantation and Its Effects on Intraocular Inflammation through Laser Flare Photometry
  20. Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line
  21. Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study
  22. New insights on circumscribed choroidal hemangioma: “bench to bedside”
  23. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
  24. Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series
  25. Choroidal vascularity profile in diabetic eyes using wide field optical coherence tomography
  26. Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy
  27. Primary small gauge pars plana vitrectomy and silicone oil endotamponade for endophthalmitis after cataract surgery: Clinical and OCT findings
  28. Biologic therapies for juvenile idiopathic arthritis-associated uveitis
  29. Improvement of retinal OCT angiograms by Sampling Kantorovich algorithm in the assessment of retinal and choroidal perfusion
  30. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity
  31. Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  32. Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
  33. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  34. In-vivo visualization of the photoreceptors using Spectralis High Magnification Module imaging in central serous chorioretinopathy
  35. Choroidal vasculature analysis in MEK inhibitor-associated retinopathy
  36. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
  37. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
  38. New trends in intravitreal anti-VEGF therapy for ROP
  39. Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study
  40. Wide-field optical coherence tomography imaging in diabetic retinopathy
  41. Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms
  42. Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
  43. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  44. Corneal and Epithelial Thickness Mapping: Comparison of Enhanced Spectral-Domain- and Spectral-Domain-Optical Coherence Tomography
  45. The choroidal rupture: current concepts and insights
  46. Real‐world outcomes of anti‐VEGF therapy in treatment‐naïve neovascular age‐related macular degeneration diagnosed on OCT angiography: the REVEAL study
  47. Comparison of two different scleral fixation techniques of posterior chamber Carlevale lens
  48. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  49. Intraretinal, sub-retinal, and sub-retinal pigmented epithelium fluid in non-exudative age-related macular degeneration: follow-up with OCT imaging
  50. Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
  51. Sildenafil in Ophthalmology: An update
  52. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders
  53. Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography
  54. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  55. Drusen ooze: Predictor for progression of dry age-related macular degeneration
  56. Functional expression and localisation of HOPS/TMUB1 in mouse lens
  57. A novel approach for scleral fixation using Carlevale lens
  58. Central serous chorioretinopathy imaging biomarkers
  59. Wide-field choroidal vascular analysis in central serous chorioretinopathy
  60. OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study
  61. Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi—the SON study
  62. Xen Gel Stent as a minimally invasive option for intraocular pressure control after DSAEK: A case study
  63. Factors predicting normal visual acuity following anatomically successful macular hole surgery
  64. Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence
  65. Epi-off-lenticule-on corneal collagen cross-linking in thin keratoconic corneas
  66. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial
  67. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study
  68. Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  69. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects
  70. Wide-field individual retinal layer thickness in healthy eyes
  71. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  72. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  73. Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy
  74. Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study
  75. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  76. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study
  77. Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery
  78. Efficacy of topical microemulsion of fatty acids of the ω-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus
  79. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
  80. The Effectiveness of 0.6% Povidone Iodine Eye Drops in Reducing the Conjunctival Bacterial Load and Needle Contamination in Patients Undergoing Anti-VEGF Intravitreal Injection: A Prospective, Randomized Study
  81. Safety of 6000 intravitreal dexamethasone implants
  82. Efficacy of Three Different Prophylactic Treatments for Postoperative Nausea and Vomiting after Vitrectomy: A Randomized Clinical Trial
  83. Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs
  84. New insight on choroidal vasculature: multimodal morphofunctional approach
  85. Wide-field choroidal thickness profile in healthy eyes
  86. Correlation of central and peripheral keratometric parameters after corneal collagen cross-linking in keratoconus patients
  87. Intraocular lens dislocation: a novel in-situ scleral refixation technique using a 25 Gauge trocar in the anterior chamber
  88. Retinal Vascular Reactivity in Central Serous Chorioretinopathy
  89. Wide-field Choroidal Vascularity in Healthy Eyes
  90. New Insights On Ocular Sarcoidosis: An Optical Coherence Tomography Angiography Study
  91. Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
  92. Corneal incision width after lens implantation: Comparing delivery systems
  93. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
  94. Confocal scanning laser microscopy in patients with postoperative endophthalmitis
  95. Optical coherence tomography angiography in age-related macular degeneration: The game changer
  96. Binocular cyclotorsion in superior vestibular neuritis
  97. Microbubble technique in failed deep anterior lamellar keratoplasty: 2-year outcomes
  98. Optical Coherence Tomography Angiography in Healthy Subjects and Diabetic Patients
  99. Reply to Comment on: ‘Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine’
  100. Bimanual microincision cataract surgery with implantation of the new Incise® MJ14 intraocular lens through a 1.4 mm incision
  101. Visual pathway involvement in multiple sclerosis: Look straight in the eyes
  102. Tear Film Stability in Sjögren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops
  103. Ocular and oto-syphilis: not a thing of the past
  104. Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach
  105. Red reflex screening highly sensitive for anterior segment abnormalities
  106. A recent finding in Fuchs uveitis: choroidal thinning
  107. Depth-Resolved Imaging of Papillary Vitreoretinal Neovascularization
  108. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine
  109. Aqueous Humor Antimicrobial Activity: In Vitro Analysis after Topical 0.5% Chloramphenicol Application
  110. Retinal Microvasculature in Nonproliferative Diabetic Retinopathy: Automated Quantitative Optical Coherence Tomography Angiography Assessment
  111. Associations of Alzheimer rsquo s disease with macular degeneration
  112. Optical Coherence Tomography Angiography in Macular Edema
  113. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma
  114. Red reflex examination in neonates: evaluation of 3 years of screening
  115. Outer Retinal and Choroidal Evaluation in Multiple Evanescent White Dot Syndrome (MEWDS): An Enhanced Depth Imaging Optical Coherence Tomography Study
  116. Deep inside Multifocal Choroiditis: an Optical Coherence Tomography Angiography approach
  117. Full-thickness choroidal thinning as a feature of Fuchs Uveitis Syndrome: quantitative evaluation of the choroid by Enhanced Depth Imaging Optical Coherence Tomography in a cohort of consecutive patients
  118. Automated Quantitative Analysis of Retinal Microvasculature in Normal Eyes on Optical Coherence Tomography Angiography
  119. Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization
  120. ‘False-friend’ images on optical coherence tomography angiography: early choroidal neovascularization or artefact?
  121. A case of unilateral circumscribed posterior keratoconus evaluated by three different imaging tools: optical coherence tomography, videokeratography, and Scheimpflug corneal tomography
  122. Hypotonic Maculopathy Secondary to Scleral Defect in Atypical Retinochoroidal Coloboma
  123. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up
  124. Endoscopic dacryocystorhinostomy with and without silicone intubation: 4 years retrospective study
  125. Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage
  126. Sliding Keratoplasty Followed by Transepithelial Iontophoresis Collagen Cross-linking for Pellucid Marginal Degeneration
  127. Canaloplasty: Current Value in the Management of Glaucoma
  128. Optical Coherence Tomography Angiography of a Choroidal Neovascularization in Adult Onset Foveomacular Vitelliform Dystrophy: Pearls and Pitfalls
  129. Dexamethasone Disodium Phosphate Penetration Into the Human Aqueous Humor After Topical Application
  130. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  131. Anterior Corneal Surface Irregularity after Descemet-Stripping Endothelial Keratoplasty for Bullous Keratopathy
  132. Reasons for Visits to an Emergency Center and Hemostatic Alterations in Patients with Recurrent Spontaneous Subconjunctival Hemorrhage
  133. A superfusion apparatus for ex vivo human eye irritation investigations
  134. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature
  135. Chloramphenicol, reaches effective concentrations against several germs.
  136. Repeatability of Retinal Macular Thickness Measurements in Healthy Subjects and Diabetic Patients with Clinically Significant Macular Edema: Evaluation of the Follow-Up System of Spectralis Optical Coherence Tomography
  137. Author's Replay: Correcting timolol prescribing in glaucoma management
  138. Long-term analysis of IOL stability of the Lewis technique for scleral fixation
  139. Optical Coherence Tomography Angiography during Follow-Up: Qualitative and Quantitative Analysis of Mixed Type I and II Choroidal Neovascularization after Vascular Endothelial Growth Factor Trap Therapy
  140. Repeatability of Retinal Macular Thickness Measurements in Patients with Clinically Significant Macular Edema Using Two Different Scanning Protocols of Spectralis Optical Coherence Tomography
  141. Posterior Corneal Surface Stability after Femtosecond Laser-Assisted Keratomileusis
  142. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
  143. Post-operative endophthalmitis caused by Acremonium falciforme with orbital and extra-orbital involvement following combined cataract and glaucoma surgery: a case report
  144. Influence of Pseudophakic Lens Capsule Opacification on Spectral Domain and Time Domain Optical Coherence Tomography Image Quality
  145. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography
  146. Timolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery
  147. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study
  148. Correction to: Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  149. Ocular penetration of topical antibiotics: study on the penetration of chloramphenicol, tobramycin and netilmicin into the anterior chamber after topical administration
  150. Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  151. Survey on retinopathy of prematurity (ROP) in Italy
  152. Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study
  153. Penetration of Prulifloxacin in human aqueous humour following oral administration
  154. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
  155. Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study
  156. Simultaneous Descemet Stripping Automated Endothelial Keratoplasty and Aphakic Iris-Fixated Intraocular Lens Implantation: A Case Series
  157. Study of Ethane Level in Exhaled Breath in Patients with Age-Related Macular Degeneration: Preliminary Study
  158. RETINAL TOXICITY OF INTRAVITREAL GENISTEIN IN A RABBIT MODEL
  159. Rituximab Treatment for Persistent Scleritis Associated with Rheumatoid Arthritis
  160. Study of alpha-lipoic acid penetration in the human aqueous after topical administration
  161. Macular Thickness Measured by Optical Coherence Tomography in a Healthy Population Before and After Uncomplicated Cataract Phacoemulsification Surgery
  162. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography
  163. Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
  164. Retinal Astrocytic Hamartoma with Associated Macular Edema: Report of Spontaneous Resolution of Macular Edema as a Result of Increasing Hamartoma Calcification
  165. Limbal anaesthesia versus topical anaesthesia for clear corneal phacoemulsification
  166. In response to comments on limbal anaesthesia for clear cornea phacoemulsification
  167. Efficacy and safety of limbal anaesthesia for clear cornea phacoemulsification
  168. Longterm results of one-site phacotrabeculectomy
  169. Post-transplant complications. cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation. Aristei C,* Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P. Bone Marrow Tr...
  170. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation
  171. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
  172. Cataracts in patients submitted to bone marrow transplantation conditioned with total body irradiation
  173. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study
  174. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
  175. Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study
  176. Nutritional intake of 2868 IDDM patients from 30 centres in Europe
  177. Cardiovascular Disease and Its Risk Factors in IDDM in Europe
  178. The Relationship Between Pregnancy and Long‐term Maternal Complications in the EURODIAB IDDM Complications Study
  179. The Relationship Between Smoking and Microvascular Complications in the EURODIAB IDDM Complications Study
  180. Study of functionality of cochlear outer hair cells in patients with retinitis pigmentosa
  181. Evaluation of functionality of cochlear outer hair cells in patients with retinitis pigmentosa and in their relatives
  182. Evoked otoacoustic emissions behaviour in retinitis pigmentosa
  183. Influences of birthweight upon brainstem maturation as reflected by auditory brainstem response (ABR) evaluation